Drug profile · INN
pozelimab-bbfg
VEOPOZ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pozelimab-bbfg (VEOPOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron UK Limited. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN pozelimab-bbfg
Brand VEOPOZ
Route INJECTION
Formulation INJECTABLE
Originator Regeneron UK Limited
Frequently asked questions
What is pozelimab-bbfg?
pozelimab-bbfg (VEOPOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron UK Limited. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pozelimab-bbfg?
VEOPOZ is a marketed brand name for pozelimab-bbfg. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pozelimab-bbfg?
pozelimab-bbfg has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.